ArticleBMC infectious diseases2025
Integrating vulnerability and hazard in malaria risk mapping: the elimination context of Senegal.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Where and why malaria persists in heterogeneous transmission settings: insights from routine health facility data.BMJ global health · 2026Article
- Recent advances in machine learning and Bayesian modeling for tropical disease prediction, diagnosis, and risk analysis: a scoping review.BMC infectious diseases · 2026Article
- Integrating vulnerability and hazard in malaria risk mapping: the elimination context of Senegal.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSignificant efforts over the past decades have successfully reduced the global burden of malaria. However, progress has stalled since 2015. In low-transmission settings, the traditional distribution of malaria along vector suitability gradients is shifting to a new profile, with the emergence of hotspots where the disease persists. To support elimination in this context, it is essential that malaria risk maps consider not only environmental and climatic factors, but also societal vulnerabilities, in order to identify remaining hotspots and ensure that no contributing factors are overlooked. In this paper, we present an integrated approach to malaria risk mapping based on the decomposition of malaria risk into two components: 'hazard', which refers to the potential presence of infected vectors (e.g. influenced by rainfall and temperature), and 'vulnerability', which is the predisposition of the population to the burden of malaria (e.g. related to health care access and housing conditions). We focus on Senegal, which has a heterogeneous malaria epidemiological profile, ranging from high transmission in the south-east to very low transmission in the north, and which aims to eliminate malaria by 2030.
methodsWe combined data from several sources: the 2017 Demographic and Health Survey (DHS) (national coverage) and the 2020-21 Malaria Indicator Survey (MIS) (south-east regions), as well as remotely sensed, high-resolution covariate data. Using Bayesian geostatistical models, we predicted the prevalence of malaria in children under five years of age with a spatial resolution of 1 km.
resultsIncluding vulnerability factors alongside hazard factors in the 2017 DHS data model improved the accuracy of predictive maps, achieving a median predictive R² of 0.64. Furthermore, models including only vulnerability factors outperformed those including only hazard factors. However, the models trained on the 2020-21 MIS data performed poorly, achieving a median R² of 0.13 at best for the model based on hazard factors, likely due to data collection during the dry season.
conclusionsThese findings highlight the importance of integrating both vulnerability and hazard factors into predictive maps. Future work could validate this approach further using routine malaria data from health management information systems, such as DHIS2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.